Trial Profile
A multicentered, randomized, double-blinded controlled Phase II clinical trial to assess the safety profile and efficacy of Benapenem in patients with complicated urinary tract infections
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Jan 2024
Price :
$35
*
At a glance
- Drugs Benapenem (Primary)
- Indications Pyelonephritis; Urinary tract infections
- Focus Adverse reactions; Therapeutic Use
- 03 Oct 2018 New trial record